Santen Pharmaceutical Co (FRA:SZD) Accounts Payable : €267 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Santen Pharmaceutical Co Accounts Payable?

Santen Pharmaceutical Co's Accounts Payable for the quarter that ended in Mar. 2024 was €267 Mil.

Santen Pharmaceutical Co's quarterly Accounts Payable increased from Sep. 2023 (€278 Mil) to Dec. 2023 (€287 Mil) but then declined from Dec. 2023 (€287 Mil) to Mar. 2024 (€267 Mil).

Santen Pharmaceutical Co's annual Accounts Payable declined from Mar. 2022 (€315 Mil) to Mar. 2023 (€314 Mil) and declined from Mar. 2023 (€314 Mil) to Mar. 2024 (€267 Mil).

Santen Pharmaceutical Co Accounts Payable Historical Data

The historical data trend for Santen Pharmaceutical Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co Accounts Payable Chart

Santen Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable

Get a 7-Day Free Trial

273.84

294.47

315.37

314.06

267.31

Santen Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															314.06	269.87	278.09	287.37	267.31

Santen Pharmaceutical Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Santen Pharmaceutical Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Santen Pharmaceutical Co (FRA:SZD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (FRA:SZD) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

SNPHY:USA SNPHF:USA 4536:Japan

Address

Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552

Website

http://www.santen.co.jp

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Santen Pharmaceutical Co (FRA:SZD) Headlines

No Headlines